Aidy
Mobile app helping people better manage chronic health conditions
Aidy is a company in healthcare based in San Francisco, CA, USA, founded in 2024.
Profile
Aidy is a mobile app that helps people live fuller lives with chronic health conditions, beginning with Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis). Our app lets users easily log their symptoms, diet, and treatments, then uses clinical indices to track disease severity and trends over time. Aidy excels at identifying patterns between diet, treatment adherence, and symptoms, giving our users a much more comprehensive and up-to-date picture of their condition to supplement clinician care.
Previously in our careers, both Max and Peter worked in health in different capacities. At the Rockefeller Foundation and the United States Senate, Max worked in public health policy and COVID-19 response, while Peter worked as an ML researcher for a number of biotech companies. After a lengthy “pivot hell” we decided to finally listen to a friend with IBD who insisted that there weren’t any decent apps to help people live with the disease. Pretty quickly, we discovered how LLMs and regular structured questionnaire responses could provide a level of patient empowerment not possible before for chronic diseases. From there, Aidy was (re)born!
Its activity falls under healthcare; the profile below is assembled from public directory data.
The business is associated with San Francisco, CA, USA.
The company is listed at the Winter 2024 stage of development.
The company reports a headcount in the 2 range.
Public records show total funding of about $5K.
Directory analysis
Aidy is a mobile application designed to help individuals with chronic health conditions, starting with Inflammatory Bowel Disease, to track symptoms, diet, and treatments. The app utilizes clinical indices to monitor disease severity and identify patterns between lifestyle factors and health outcomes, providing users with a comprehensive view of their condition to complement clinician care.
Positioning: Aidy positions itself as a data-driven companion tool for chronic disease management, targeting patients who seek more detailed self-monitoring alongside traditional medical care. Its focus on IBD and integration of clinical metrics differentiates it within the broader health‑tech market, though it remains early-stage with limited resources.
Note: Aidy offers a mobile platform for tracking chronic disease symptoms and diet, aimed at improving patient insight and care coordination.
Auto-generated directory analysis from public data · updated 11 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Founded | 2024 |
| Employees | 2 |
| Stage | Winter 2024 |
| Total funding | $500,000 |
Website: www.aidyhq.com
Browse related
Create a free account